We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Health

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is Adult T-Cell Leukemia?

By Amy Hunter
Updated: May 17, 2024
Views: 8,880
Share

Adult T-cell leukemia (ATL) is a rare type of cancer that develops in immune t-cells. ATL is caused by human t-cell leukemia/lymphoma virus type 1, or HTLV-1. This cancer is aggressive, and most patients die within one year of diagnosis. Adult t-cell leukemia is a form of non-Hodgkin's lymphoma. ATL affects adults, and is most common in the Caribbean and Japan. It is noted in less frequent clusters in Western countries.

HTLV-1, the virus responsible for ATL is a retrovirus. It can be transmitted through blood, such as shared needles or a blood transfusion, sexual contact, or from mother to child. The latency period for developing adult t-cell leukemia after exposure to HTLV-1 is an average of 30 years. Less than five percent of people who are carriers of HTLV-1 develop ATL.

Visible symptoms of adult t-cell leukemia include skin lesions and enlarged lymph nodes. Other symptoms include an increased susceptibility to infections, high levels of blood calcium, bone lesions and an enlarged liver and spleen. There are four sub-types of the illness, acute and lymphomatous, which both grow very quickly, and less aggressive smoldering and chronic ATL.

Symptoms develop rapidly in acute ATL. The patient typically experiences enlarged lymph nodes in the groin, armpit and neck, fatigue, skin rash, and elevated levels of calcium in the blood, which can lead to severe constipation and an irregular heartbeat. Lymphomatous ATL is confined to the lymph nodes. Chronic ATL progresses slowly, and symptoms include enlarged lymph nodes as well as enlarged organs such as spleen and liver, as well as skin rash and fatigue. Smoldering ATL progresses very slowly and presents mild symptoms such as lesions on the skin.

Diagnosis of adult t-cell leukemia is made by biopsy. The healthcare provider will view abnormal skin tissue or tumor tissue through a microscope to make a diagnosis. He or she may also perform a blood test to measure levels of calcium in the blood, as well as white blood cell counts. Once a diagnosis is made, the doctor may order a CT scan of the spleen, liver, chest, and abdomen as well as a bone marrow biopsy to determine the extent of the illness.

Because adult t-cell leukemia is relatively rare, it is difficult to conduct clinical trials to develop a recommended treatment protocol. Standard treatment for ATL is similar to other forms of t-cell lymphoma, which is a combination of chemotherapy drugs. Patients may also take antiviral medication and interferon to treat the HTLV-1 infection. Some healthcare providers recommend bone marrow transplants for patients that enter remission.

Share
WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Editors' Picks

Discussion Comments
By Lostnfound — On May 23, 2014

@Grivusangel -- That is sad. A man in our city had it and his chemotherapy drug had been recalled, so they had him on Gleevec, but I don't think it did much good. He was a teacher, so everybody knew him.

It really stinks when the FDA issues recalls on drugs that actually help people. I guess they have to if the drug isn't safe, but when it helps save lives, I just have a problem with that.

By Grivusangel — On May 22, 2014

A man in our community who had played football in the pros died from this not long ago. I think he managed six months in remission. He lived about 18 months after diagnosis, which the doctors said was much longer than most patients who have this kind of leukemia.

The doctors were looking to try a bone marrow transplant, and a bone marrow drive was held, but there weren't any matches they found before he died. It was very, very sad.

Share
https://www.wisegeek.net/what-is-adult-t-cell-leukemia.htm
Copy this link
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.